Phosphine Ligand Effects in Nickel-Catalyzed Alkene Migratory Hydroalkylation
Synthesis · 04.06.2024 · 56 (11) · 1741-1748
DOI: 10.1055/a-2204-8921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 04.06.2024. Verfasst von Qing-Wei Zhu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Science Foundation of Anhui Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Catalytic alkene hydroalkylation has provided to be an efficient method for synthesizing C(sp3) centers, from readily available and inexpensive alkene starting materials through alkene hydrometallation followed by cross-coupling. One of the major tasks in this field is to develop diverse ligands to achieve regioselective control. Herein, we report the investigation of nickel–triphenylphosphine-catalyzed remote hydroalkylation of alkenyl amides to access α-branched amines. Various alkenes and alkyl iodides are suitable substrates to deliver the desired products with excellent regioselectivities (>20:1 regioisomeric ratio). Density functional theory calculations reveal the reaction mechanism.
Förderung
- National Science Foundation of Anhui Province
- China Postdoctoral Science Foundation
Zitieren
APA
Zhu, Q., Liu, D., Lu, X., Fu, Y., Li, Z., Wang, J., & Nie, W. (2024). Phosphine Ligand Effects in Nickel-Catalyzed Alkene Migratory Hydroalkylation. Synthesis, 56(11), 1741-1748. https://doi.org/10.1055/a-2204-8921
Vancouver
Zhu Q, Liu D, Lu X, Fu Y, Li Z, Wang J, et al. Phosphine Ligand Effects in Nickel-Catalyzed Alkene Migratory Hydroalkylation. Synthesis. 2024;56(11):1741-1748. doi:10.1055/a-2204-8921
BibTeX
@article{Zhu2024,
author = {Zhu, Qing-Wei and Liu, Deguang and Lu, Xi and Fu, Yao and Li, Zhen and Wang, Jia-Wang and Nie, Wan},
title = {Phosphine Ligand Effects in Nickel-Catalyzed Alkene Migratory Hydroalkylation},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {11},
pages = {1741--1748},
doi = {10.1055/a-2204-8921}
}
EUVIMED